Radiofrequency Splanchnic Denervation Versus Retrocrural Neurolytic Celiac Block for Pancreatic Cancer Pain

Not Applicable

• Conditions: Chronic Pain
• Interventions: Procedure: radiofrequency splanchnic denervation; Procedure: retrocrural celiac denervation

• Registration Number: NCT03886298
• Lead Sponsor: Assiut University

Brief Summary

The investigators will evaluate the analgesic efficacy of radiofrequency splanchnic nerve denervation versus neurolytic retrocrural celiac denervation for patients with abdominal pain due to cancer pancreas

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-03-20
• Study First Submitted QC: 2019-03-21
• Study First Posted: 2019-03-22
• Study Start: 2019-04-10
• Status Verified: 2019-07
• Last Update Submitted: 2019-07-03
• Last Update Posted: 2019-07-08
• Primary Completion: 2020-04-10
• Study Completion: 2020-06-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• patients with abdominal pain due to cancer pancreas

Exclusion Criteria

• coagulopathy
• infection at site of the procedure

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
radiofrequency splanchnic denervation	radiofrequency splanchnic denervation	-
retrocrural celiac denervation	retrocrural celiac denervation	-

Primary Outcome Measures

Name	Time	Method
the percentage of patients that gain more than 50% reduction of their pain on VAS pain score	6 months postoperatively	VAS pain scale is a tool for measurement of pain intensity scored from 0 to 10 in which 0 + no pain and 10 + the worst pain immaginable

Trial Locations

Locations (1)

Diab; 🇪🇬 Assiut, Assuit, Egypt